In regards to how RG device is performing in Europe he says the technology has been performing marvelously.
He says he is very confident in plc's future.
He says they believe that both existing and new applications will drive plc's business far.
And in the first actual comment I have seen on the US trial he says interim analysis early 2014.
Certainly worth a read.
i seen the solo video at plc web site but did not hear the ceo mention about the US trial saying interim analysis early 2014 "does that mean FDA decision by then ?" can You give the link to the interview or where to find it ?
The interview was by bio-wire. Go to the bio-wire website or the smallcapnetwork website. The interview is in both places.
Interim analysis means determination of total enrollment required for the trial. Hopefully will be 326.